References
Mannstadt M, Bilezikian JP, Thakker RV, Hannan FM, Clarke BL, Rejnmark L, Mitchell DM, Vokes TJ, Winer KK, Shoback DM (2017) Hypoparathyroidism. Nat Rev Dis Primers 3:17055
Brandi ML, Bilezikian JP, Shoback D, Bouillon R, Clarke BL, Thakker RV, Khan AA, Potts JT Jr (2016) Management of hypoparathyroidism: summary statement and guidelines. J Clin Endocrinol Metab 101:2273–2283
Mantovani G, Bastepe M, Monk D, de Sanctis L, Thiele S, Usardi A, Ahmed SF, Bufo R, Choplin T, De Filippo G, Devernois G, Eggermann T, Elli FM, Freson K, García Ramirez A, Germain-Lee EL, Groussin L, Hamdy N, Hanna P, Hiort O, Jüppner H, Kamenický P, Knight N, Kottler ML, Le Norcy E, Lecumberri B, Levine MA, Mäkitie O, Martin R, Martos-Moreno GÁ, Minagawa M, Murray P, Pereda A, Pignolo R, Rejnmark L, Rodado R, Rothenbuhler A, Saraff V, Shoemaker AH, Shore EM, Silve C, Turan S, Woods P, Zillikens MC, Perez de Nanclares G, Linglart A (2018) Diagnosis and management of pseudohypoparathyroidism and related disorders: first international consensus statement. Nat Rev Endocrinol 14:476–500
Abate EG, Clarke BL (2017) Review of hypoparathyroidism. Front Endocrinol (Lausanne) 7:172
Bilezikian JP, Brandi ML, Cusano NE, Mannstadt M, Rejnmark L, Rizzoli R, Rubin MR, Winer KK, Liberman UA, Potts JT Jr (2016) Management of hypoparathyroidism: present and future. J Clin Endocrinol Metab 101:2313–2324
De Sanctis V, Soliman A, Fiscina B (2012) Hypoparathyroidism: from diagnosis to treatment. Curr Opin Endocrinol Diabetes Obes 19:435–442
Monis EL, Mannstadt M (2015) Hypoparathyroidism - disease update and emerging treatments. Ann Endocrinol (Paris) 76:84–88
Winer KK, Sinaii N, Peterson D, Sainz B Jr, Cutler GB Jr (2008) Effects of once versus twice-daily parathyroid hormone 1–34 therapy in children with hypoparathyroidism. J Clin Endocrinol Metab 93:3389–3395
Winer KK, Sinaii N, Reynolds J, Peterson D, Dowdy K, Cutler GB Jr (2010) Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1–34 versus calcitriol and calcium. J Clin Endocrinol Metab 95:2680–2688
Winer KK, Fulton KA, Albert PS, Cutler GB Jr (2014) Effects of pump versus twice-daily injection delivery of synthetic parathyroid hormone 1–34 in children with severe congenital hypoparathyroidism. J Pediatr 165:556-563.e1
Winer KK, Kelly A, Johns A, Zhang B, Dowdy K, Kim L, Reynolds JC, Albert PS, Cutler GB Jr (2018) Long-term parathyroid hormone 1–34 replacement therapy in children with hypoparathyroidism. J Pediatr 203:391-399.e1
Saraff V, Rothenbuhler A, Högler W, Linglart A (2018) Continuous subcutaneous recombinant parathyroid hormone (1–34) infusion in the management of childhood hypoparathyroidism associated with malabsorption. Horm Res Paediatr 89:271–277
Levy I, Licht C, Daneman A, Sochett E, Harrington J (2015) The impact of hypoparathyroidism treatment on the kidney in children: long-term retrospective follow-up study. J Clin Endocrinol Metab 100:4106–4113
Raue F, Pichl J, Dörr HG, Schnabel D, Heidemann P, Hammersen G, Jaursch-Hancke C, Santen R, Schöfl C, Wabitsch M, Haag C, Schulze E, Frank-Raue K (2011) Activating mutations in the calcium-sensing receptor: genetic and clinical spectrum in 25 patients with autosomal dominant hypocalcaemia - a German survey. Clin Endocrinol (Oxf) 75:760–765
Lienhardt A, Bai M, Lagarde JP, Rigaud M, Zhang Z, Jiang Y, Kottler ML, Brown EM, Garabédian M (2001) Activating mutations of the calcium-sensing receptor: management of hypocalcemia. J Clin Endocrinol Metab 86:5313–5323
Mitchell DM, Regan S, Cooley MR, Lauter KB, Vrla MC, Becker CB, Burnett-Bowie SA, Mannstadt M (2012) Long-term follow-up of patients with hypoparathyroidism. J Clin Endocrinol Metab 97:4507–4514
Saha S, Kandasamy D, Sharma R, Bal C, Sreenivas V, Goswami R (2020) Nephrocalcinosis, renal dysfunction, and calculi in patients with primary hypoparathyroidism on long-term conventional therapy. J Clin Endocrinol Metab 105:dgz319
Chinoy A, Skae M, Babiker A, Kendall D, Mughal MZ, Padidela R (2017) Impact of intercurrent illness on calcium homeostasis in children with hypoparathyroidism: a case series. Endocr Connect 6:589–594
Dayal D, Gupta A, Gupta S, Dutta A (2019) Recombinant parathyroid hormone for hypoparathyroidism in children: a narrative review. Pediatr Endocrinol Diabetes Metab 25:194–201
Peissig K, Condie BG, Manley NR (2018) Embryology of the parathyroid glands. Endocrinol Metab Clin North Am 47:733–742
Mannstadt M, Bertrand G, Muresan M, Weryha G, Leheup B, Pulusani SR, Grandchamp B, Jüppner H, Silve C (2008) Dominant-negative GCMB mutations cause an autosomal dominant form of hypoparathyroidism. J Clin Endocrinol Metab 93:3568–3576
Guan B, Welch JM, Sapp JC, Ling H, Li Y, Johnston JJ, Kebebew E, Biesecker LG, Simonds WF, Marx SJ, Agarwal SK (2016) GCM2-activating mutations in familial isolated hyperparathyroidism. Am J Hum Genet 99:1034–1044
Ding C, Buckingham B, Levine MA (2001) Familial isolated hypoparathyroidism caused by a mutation in the gene for the transcription factor GCMB. J Clin Invest 108:1215–1220
Baumber L, Tufarelli C, Patel S, King P, Johnson CA, Maher ER, Trembath RC (2005) Identification of a novel mutation disrupting the DNA binding activity of GCM2 in autosomal recessive familial isolated hypoparathyroidism. J Med Genet 42:443–448
Thomée C, Schubert SW, Parma J, Lê PQ, Hashemolhosseini S, Wegner M, Abramowicz MJ (2005) GCMB mutation in familial isolated hypoparathyroidism with residual secretion of parathyroid hormone. J Clin Endocrinol Metab 90:2487–2492
Bowl MR, Mirczuk SM, Grigorieva IV, Piret SE, Cranston T, Southam L, Allgrove J, Bahl S, Brain C, Loughlin J, Mughal Z, Ryan F, Shaw N, Thakker YV, Tiosano D, Nesbit MA, Thakker RV (2010) Identification and characterization of novel parathyroid-specific transcription factor Glial Cells Missing Homolog B (GCMB) mutations in eight families with autosomal recessive hypoparathyroidism. Hum Mol Genet 19:2028–2038
Horwitz MJ, Stewart AF (2008) Hypoparathyroidism: is it time for replacement therapy? J Clin Endocrinol Metab 93:3307–3309
Di Maio S, Soliman AT, De Sanctis V, Kattamis CC (2018) Current treatment of hypoparathyroidism: theory versus reality waiting guidelines for children and adolescents. Acta Biomed 89:122–131
Author information
Authors and Affiliations
Contributions
Pediredla Karunakar, Thiagarajan Narayanasamy Rajavelu, Bobbity Deepthi, Abarna Thangaraj, and Aakash Chandran Chidambaram managed the patient, reviewed the literature, and drafted the manuscript. Sriram Krishnamurthy managed the patient, reviewed the literature, and critically revised the manuscript. All authors contributed to the review of literature and drafting of the manuscript and approved the final version of the manuscript. Sriram Krishnamurthy shall act as guarantor of the paper.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This refers to the article that can be found at https://doi.org/10.1007/s00467-021-05230-5.
Rights and permissions
About this article
Cite this article
Karunakar, P., Krishnamurthy, S., Rajavelu, T.N. et al. A child with tetany, convulsions, and nephrocalcinosis: Answers. Pediatr Nephrol 36, 4119–4122 (2021). https://doi.org/10.1007/s00467-021-05238-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-021-05238-x